✦ LIBER ✦

TCT-590 Three-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Single De Novo Native Coronary Lesions: The TARGET I Trial

✍ Scribed by Xu, Bo; Zhao, Yelin; Yang, Yuejin; Changsheng, Ma; Han, Yaling; Chen, Shao Liang; Li, Hui; Zhang, Ruiyan; Leon, Martin; Gao, Run-Lin

Book ID: 127015810
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 74 KB
Volume: 64
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2014.07.654

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-20 Two-Year Clinical Follow-Up of th

TCT-20 Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I Trial

✍ Xu, Bo; Gao, Run-Lin; Lansky, Alexandra; Yang, Yuejin; Changsheng, Ma; Han, Yali 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 100 KB

TCT-242: First Report of A Novel Ablumin

TCT-242: First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

TCT-181 Safety and Efficacy of a Novel A

TCT-181 Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET II Trials

✍ Gao, Run-Lin; Xu, Bo; Lansky, Alexandra; Yang, Yuejin; Zhang, Ruiyan; Changsheng 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Randomized Comparison of Everolimus-Elut

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial

✍ Stone, G. W.; Midei, M.; Newman, W.; Sanz, M.; Hermiller, J. B.; Williams, J.; F 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 436 KB

TCT-212 Efficacy of the Novel BioMime Si

TCT-212 Efficacy of the Novel BioMime Sirolimus-Eluting Stents with a Biodegradable Polymer in the Treatment of De Novo Coronary Lesions: An Angiographic Subanalysis of the Combined meriT-1 and meriT-2 Prospective Clinical Trials

✍ Costa, Ricardo A.; Abizaid, Alexandre; Dani, Sameer; Joshi, Hasit; Wander, Gurpr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB